These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 30721408)

  • 1. Retinal α-synuclein deposits in Parkinson's disease patients and animal models.
    Veys L; Vandenabeele M; Ortuño-Lizarán I; Baekelandt V; Cuenca N; Moons L; De Groef L
    Acta Neuropathol; 2019 Mar; 137(3):379-395. PubMed ID: 30721408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
    Mammadova N; Summers CM; Kokemuller RD; He Q; Ding S; Baron T; Yu C; Valentine RJ; Sakaguchi DS; Kanthasamy AG; Greenlee JJ; Heather West Greenlee M
    Neurobiol Dis; 2019 Jan; 121():1-16. PubMed ID: 30218757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Alpha-Synuclein Deposits in Parkinson's Disease: A Focus on the Human Retina.
    Di Pippo M; Fragiotta S; Di Staso F; Scuderi L; Abdolrahimzadeh S
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retina as a Model to Study In Vivo Transmission of α-Synuclein in the A53T Mouse Model of Parkinson's Disease.
    Mammadova N; Baron T; Verchère J; Greenlee JJ; Greenlee MHW
    Methods Mol Biol; 2021; 2224():75-85. PubMed ID: 33606207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal hyperspectral imaging in mouse models of Parkinson's disease and healthy aging.
    Trlin P; Gong J; Tran KKN; Wong VHY; Lee PY; Hoang A; Zhao D; Beauchamp LC; Lim JKH; Metha A; Barnham KJ; Finkelstein DI; Bui BV; Bedggood P; Nguyen CTO
    Sci Rep; 2024 Jul; 14(1):16089. PubMed ID: 38997314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
    Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
    Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retina-to-brain spreading of α-synuclein after intravitreal injection of preformed fibrils.
    Pérez-Acuña D; Rhee KH; Shin SJ; Ahn J; Lee JY; Lee SJ
    Acta Neuropathol Commun; 2023 May; 11(1):83. PubMed ID: 37210559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein nonhuman primate models of Parkinson's disease.
    Marmion DJ; Kordower JH
    J Neural Transm (Vienna); 2018 Mar; 125(3):385-400. PubMed ID: 28434076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does retina play a role in Parkinson's Disease?
    Mohana Devi S; Mahalaxmi I; Aswathy NP; Dhivya V; Balachandar V
    Acta Neurol Belg; 2020 Apr; 120(2):257-265. PubMed ID: 31965540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein-Based Animal Models of Parkinson's Disease: Challenges and Opportunities in a New Era.
    Visanji NP; Brotchie JM; Kalia LV; Koprich JB; Tandon A; Watts JC; Lang AE
    Trends Neurosci; 2016 Nov; 39(11):750-762. PubMed ID: 27776749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in understanding the function of alpha-synuclein: implications for Parkinson's disease.
    Calabresi P; Di Lazzaro G; Marino G; Campanelli F; Ghiglieri V
    Brain; 2023 Sep; 146(9):3587-3597. PubMed ID: 37183455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-synuclein in the inner retina in parkinson disease.
    Bodis-Wollner I; Kozlowski PB; Glazman S; Miri S
    Ann Neurol; 2014 Jun; 75(6):964-6. PubMed ID: 24816946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated α-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson's disease.
    Lin CW; Lai TT; Chen SJ; Lin CH
    Geroscience; 2022 Jun; 44(3):1551-1562. PubMed ID: 35484471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.
    Dijkstra AA; Voorn P; Berendse HW; Groenewegen HJ; ; Rozemuller AJ; van de Berg WD
    Mov Disord; 2014 Sep; 29(10):1244-51. PubMed ID: 24996051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease biomarkers based on α-synuclein.
    Fayyad M; Salim S; Majbour N; Erskine D; Stoops E; Mollenhauer B; El-Agnaf OMA
    J Neurochem; 2019 Sep; 150(5):626-636. PubMed ID: 31265130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes.
    Indrieri A; Pizzarelli R; Franco B; De Leonibus E
    Front Neurosci; 2020; 14():567129. PubMed ID: 33192254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced cerebral blood flow in an
    Biju KC; Shen Q; Hernandez ET; Mader MJ; Clark RA
    J Cereb Blood Flow Metab; 2020 Dec; 40(12):2441-2453. PubMed ID: 31856640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.
    Shannon KM; Keshavarzian A; Mutlu E; Dodiya HB; Daian D; Jaglin JA; Kordower JH
    Mov Disord; 2012 May; 27(6):709-15. PubMed ID: 21766334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein and Lewy pathology in Parkinson's disease.
    Kalia LV; Kalia SK
    Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Synuclein in Parkinson's disease: pathogenic function and translation into animal models.
    Eschbach J; Danzer KM
    Neurodegener Dis; 2014; 14(1):1-17. PubMed ID: 24080741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.